Lightbridge Provides Update on Nuclear Fuel

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Lightbridge Provides Update on Nuclear Fuel Commercialization Plan, Business Update and Financial Results for Second Quarter 2016

RESTON, Va., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Lightbridge Corporation (NASDAQ: LTBR ) today issued an update on its commercialization strategy and provided a business update for the second quarter ended June 30, 2016.

Seth Grae, President & Chief Executive Officer of Lightbridge Corporation, commented, “We have achieved important milestones during the second quarter. We have been approved to continue to trade on Nasdaq and have received a $2.8 million convertible preferred financing from General International Holdings Inc. (GIH), an entity controlled by Mr. Xingping Hou, at a significant premium to the market price at the time of the agreement. We believe the terms of the $2.8 million financing were favorable for shareholders and we appreciate the support Mr. Hou has shown.  This investment, combined with a $1 million investment from Aspire Capital announced in June, strengthens our balance sheet while allowing us to continue executing on our business plan. We have also agreed to milestones-based funding of an additional $4 million from Aspire Capital.”

“We continue to advance our discussion with key industry partners for fuel sample fabrication for irradiation testing in the Halden research reactor and manufacturing of full-length fuel rods for lead test assembly operation in a commercial power reactor.  We are also pleased with strong support we have been receiving from the industry, including from four of the leading U.S. nuclear operators, which continue to advise Lightbridge on our nuclear fuel program.”

“We have received patents for our breakthrough metallic nuclear fuel technology in key markets including the U.S., Canada, China, Japan, South Korea, Russia, European Union-member countries and other global markets. Securing our intellectual property rights is an important step in advancing our global strategy. We are working with key industry players and look forward to announcing our first major commercial arrangement for deploying our metallic fuel later this year.  Through these strategic partnerships and joint ventures, we expect to be in position to leverage our partners' existing resources and capabilities to cost effectively bring our fuel to market globally, which has the potential to generate hundreds of millions of dollars in annual royalty revenues to Lightbridge and our shareholders.”

Financial Highlights

Recent Financings Completed

As mentioned above, the Company closed on $2.8 million of a convertible preferred stock financing on August 2, 2016 which has improved the Company’s current cash and working capital positions.

On June 28, 2016, the Company entered into a Securities Purchase Agreement with Aspire Capital pursuant to which the Company has agreed to sell up to $5.0 million of shares of the Company’s common stock to Aspire Capital, without an underwriter or placement agent.  Pursuant to the Securities Purchase Agreement, the Company sold 371,400 shares of common stock and 295,267 pre-funded warrants at an exercise price of $0.05 per share to Aspire Capital on June 28, 2016 for $1.0 million. The Securities Purchase Agreement provides for the sale of up to an additional $4.0 million of the Company’s common stock to Aspire Capital upon the achievement of certain milestones.

Balance Sheet Overview and Reverse Stock Split

At June 30, 2016 the Company had approximately $1.5 million in cash compared to approximately $1.0 million in cash and restricted cash at December 31, 2015. The Company had approximately $0.4 million in working capital at June 30, 2016 as compared to working capital of approximately $0.1 million at December 31, 2015.  Stockholders' equity was approximately $1.1 million compared to stockholders’ deficiency of approximately $1.5 million at December 31, 2015.

On July 20, 2016, at the opening of trading, we effected a one-for-five reverse split of our common shares.  The common shares began trading on a split-adjusted basis on July 20, 2016. All share data herein has been retroactively adjusted for the reverse stock split. Common shares outstanding at June 30, 2016 totaled 4,799,906.

The primary sources of cash available to us presently are equity investments through our security purchase agreement and equity line purchase agreement with Aspire Capital Fund, LLC, and our ATM agreement with MLV & Co. LLC. We have no debt or debt credit lines and we have financed our operations to date through the sale of our equity securities and our consulting revenue. We did not raise any capital in 2016 from our ATM financing agreement, and we have raised approximately $2 million for the six months ended June 30, 2016 through our equity line purchase agreement with Aspire.

Operating Results – Second Quarter of Fiscal 2016 Compared to Second Quarter of Fiscal 2015

For the second quarter ended June 30, 2016, Lightbridge’s net loss was approximately $1.3 million, or a loss of $0.30 per share, on revenue of $0.1 million.  In the same quarter of 2015, the net loss was $1.0 million, or loss per share of $0.28 per share, on revenue of $0.3 million. All revenue was generated from consulting services. Stock-based compensation expense was $0.4 million for the quarter ended June 30, 2016 compared to $0.7 million for the quarter ended June 30, 2015. Excluding the impact of warrant revaluation for the derivative warrant liability, net loss for the quarters ended June 30, 2016 and 2015 would have been $1.6 million and $1.5 million, respectively. (See “About Non-GAAP Financial Measures” near the end of this release).  For the six months ended June 30, 2016, the Company’s cash flows used in operating activities were $2.4 million versus $1.8 million used in operating activities for the same period of 2015. This increase is primarily due to increased spending on research and development of approximately $0.4 million and an increase in general and administrative expenses of approximately $0.2 million.

Commercial Nuclear Energy Market Opportunity

The commercial nuclear energy industry is projected to grow rapidly at a time of rising global demand for reliable, carbon-free, base load electric power. There are currently 436 operable civil nuclear reactors in 30 countries around the world, with 67 reactors under construction and 488 on order, planned or proposed, according to the World Nuclear Association. By 2040, the International Energy Agency projects a 58% increase in nuclear capacity from a combination of power uprates and reactor construction. While some older reactors are closing in the U.S. and Europe, the global market is growing.

For a detailed description of the value proposition of Lightbridge fuel technology, including projected incremental annual net operating cash flows and return on investment for a nuclear power plant operator using Lightbridge fuel at various wholesale electricity prices, visit http://bit.ly/1jLXpoY . The advantages of Lightbridge's metallic fuel design have been confirmed in independent third-party analyses. These reports, which include a peer-reviewed article published in Nuclear Technology and reports by Siemens, are available for download at http://ir.ltbridge.com/ .

2016 Second Quarter Conference Call

Lightbridge will host a conference call on Friday, August 12th at 11:00 a.m. Eastern Time to discuss the company's financial results for the second quarter ending June 30, 2016, as well as the Company's corporate progress and other meaningful developments.

Interested parties can access the conference call by calling 866-320-0203 for U.S. callers, or +1- 785-424-1634 for international callers.  The call will be available on the Company’s website via webcast at http://ir.ltbridge.com/events.cfm . The conference call will be led by Seth Grae, President and Chief Executive Officer and other Lightbridge executives will also be available to answer questions. Questions may also be submitted in writing before or during the conference call to ir@ltbridge.com . 

A webcast will also be archived on the Company’s website and a telephone replay of the call will be available approximately one hour following the call, through midnight September 12, 2016, and can be accessed by calling: 877-481-4010 (U.S. callers) or +1- 919-882-2331 (international callers) and entering conference ID: 10072.

About Non-GAAP Financial Measures

This press release contains non-GAAP financial measures for earnings that exclude warrant revaluation income. Net income excluding warrant revaluation income is not a measure of performance calculated in accordance with generally accepted accounting principles in the United States (“GAAP”). The Company believes the presentation of net income excluding warrant revaluation income is relevant and useful by enhancing the readers’ ability to understand the Company’s operating performance. The Company’s management utilizes net income excluding warrant revaluation income as a means to measure operating performance. The table below reconciles net income (loss) excluding revaluation income, a non-GAAP measure, to net income for the three months ended June 30, 2016 and 2015.

(in millions)        
    Quarter Ended    Quarter Ended
    June 30,    June 30,
    2016     2015  
Net loss   $ (1.3 )   $ 1.0  
Adjustments:        
Warrant revaluation income     0.3       0.5  
Net Loss Excluding Warrant Revaluation Income   $ (1.6 )   $ (1.5 )
                 

Lightbridge Corporation

Lightbridge is a nuclear energy company based in Reston, Virginia, USA. The Company develops proprietary next generation nuclear fuel technologies for current and future nuclear reactor systems. Lightbridge's breakthrough fuel technology is establishing new global standards for safe and clean nuclear power and leading the way to a sustainable energy future. The Company also provides comprehensive advisory services for established and emerging nuclear programs based on a philosophy of transparency, non-proliferation, safety and operational excellence. Lightbridge consultants provide integrated strategic advice and expertise across a range of disciplines including regulatory affairs, nuclear reactor procurement and deployment, reactor and fuel technology and international relations. The Company leverages those broad and integrated capabilities by offering its services to commercial entities and governments with a need to establish or expand nuclear industry capabilities and infrastructure.

To receive Lightbridge Corporation updates via e-mail, subscribe at http://ir.ltbridge.com/alerts.cfm .

Lightbridge is on Twitter. Sign up to follow @LightbridgeCorp at http://twitter.com/lightbridgecorp .

Forward Looking Statements With the exception of historical matters, the matters discussed in this news release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Company's competitive position, the timing of demonstration testing and commercial production, the Company’s entry into agreements with nuclear fuel manufacturers and the timing thereof, the potential impact of the U.S. Clean Energy Plan and similar regulations, the Company’s anticipated financial resources and position, the Company’s product and service offerings and the expected market for the Company’s product and service offerings.  These statements are based on current expectations on the date of this news release and involve a number of risks and uncertainties that may cause actual results to differ significantly from such estimates. The risks include, but are not limited to, the degree of market adoption of the Company's product and service offerings; market competition; dependence on strategic partners; demand for fuel for nuclear reactors; and the Company's ability to manage its business effectively in a rapidly evolving market, as well as other factors described in Lightbridge's filings with the Securities and Exchange Commission .  Lightbridge does not assume any obligation to update or revise any such forward-looking statements, whether as the result of new developments or otherwise.  Readers are cautioned not to put undue reliance on forward-looking statements.

*** tables follow ***

 

Lightbridge Corporation
Condensed Consolidated Balance Sheets
 
        June 30,   December 31,  
          2016       2015    
        Unaudited      
  ASSETS            
Current Assets            
  Cash and cash equivalents   $   1,484,099   $   623,184    
  Restricted cash       35,021       325,832    
  Accounts receivable - project revenue and reimbursable project costs       69,696       139,797    
  Prepaid expenses and other current assets       189,511       168,029    
    Total Current Assets       1,778,327       1,256,842    
Other Assets            
  Patent costs       1,048,518       950,594    
  Total Assets   $   2,826,845   $   2,207,436    
               
  LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY)            
Current Liabilities            
  Accounts payable and accrued liabilities   $   1,343,984   $   1,182,371    
  Note payable       68,036       -    
    Total Current Liabilities       1,412,020       1,182,371    
Long-Term Liabilities            
  Deferred lease abandonment liability        112,700       196,938    
  Derivative warrant liability       198,955       2,327,195    
  Total Liabilities       1,723,675       3,706,504    
               
             
               
Stockholders' Equity (Deficiency)            
  Preferred stock, $0.001 par value, 10,000,000 authorized shares, no shares issued and outstanding       -       -    
  Common stock, $0.001 par value, 100,000,000 authorized, 4,799,906 shares outstanding at June 30, 2016 and 3,725,819 shares outstanding at December 31, 2015         4,800         3,726    
  Additional paid-in capital         77,101,722         72,868,647    
  Accumulated Deficit         (76,003,352 )       (74,371,441 )  
    Total Stockholders' Equity (Deficiency)         1,103,170         (1,499,068 )  
Total Liabilities and Stockholders' Equity (Deficiency)   $   2,826,845   $   2,207,436    
                     
Lightbridge Corporation
Unaudited Condensed Consolidated Statements of Operations
   
        Three Months Ended     Six Months Ended  
        June 30,     June 30,  
          2016       2015         2016       2015    
Revenue:                      
                         
Consulting Revenue   $   122,377   $   298,162     $   288,923   $   422,057    
                         
Cost of  Consulting Services Provided       62,137       275,662         130,362       333,054    
                         
Gross Margin       60,240       22,500         158,561       89,003    
                         
Operating Expenses                      
  General and administrative       1,112,582       1,108,807         2,208,694       2,039,100    
  Research and development expenses       419,498       394,715         1,005,748       607,545    
Total Operating Expenses       1,532,080       1,503,522         3,214,442       2,646,645    
                         
Operating Loss       (1,471,840 )     (1,481,022 )       (3,055,881 )     (2,557,642 )  
                         
Other Income and (Expenses)                      
  Warrant revaluation       311,645       460,265         1,565,499       1,658,251    
  Warrant modification expense       (129,369 )     -         (129,369 )     -    
  Investment income       274       163         274       323    
  Other income (expenses)       (7,915 )     (762 )       (12,434 )     (3,274 )  
Total Other Income and (Expenses)       174,635       459,666         1,423,970       1,655,300    
                         
 Net loss before income taxes       (1,297,205 )     (1,021,356 )       (1,631,911 )     (902,342 )  
                         
Income taxes       -       -         -       -    
                         
Net loss   $   (1,297,205 ) $   (1,021,356 )   $   (1,631,911 ) $   (902,342 )  
                         
Net Loss Per Common Share,                      
  Basic and Diluted   $   (0.30 ) $   (0.28 )   $   (0.40 ) $   (0.25 )  
                         
Weighted Average Shares Outstanding       4,273,031       3,616,575         4,074,104       3,616,575    
                                       
Lightbridge Corporation
 Unaudited Condensed Consolidated Statements of Cash Flows
 
          Six Months Ended
          June 30,
            2016       2015  
  Operating Activities:          
    Net Loss   $   (1,631,911 ) $   (902,342 )
  Adjustments to reconcile net loss from operations to net cash used in operating activities:          
    Stock-based compensation       550,552       782,036  
    Warrant modification expense       129,369       -  
    Warrant revaluation income       (1,565,499 )     (1,658,251 )
  Changes in operating working capital items:          
    Accounts receivable - fees and reimbursable project costs       70,101       221,942  
    Prepaid expenses and other  assets       (21,482 )     1,389  
    Accounts payable and accrued liabilities       231,516       (201,097 )
    Deferred lease abandonment liability       (154,141 )     -  
  Net Cash Used In Operating Activities       (2,391,495 )     (1,756,323 )
               
  Investing Activities:          
    Patent costs       (97,924 )     (50,215 )
  Net Cash Used In Investing Activities       (97,924 )     (50,215 )
               
  Financing Activities:          
    Net proceeds from the issuance of common stock       2,991,487       -  
    Payments for stock offering costs       -       (42,097 )
    Proceeds from the issuance of note payable       135,000       -  
    Repayment of note payable       (66,964 )     -  
    Restricted cash       290,811       (324 )
  Net Cash Provided by (Used In) Financing Activities       3,350,334       (42,421 )
               
  Net Increase (Decrease) In Cash and Cash Equivalents       860,915       (1,848,959 )
               
  Cash and Cash Equivalents, Beginning of Period       623,184       4,220,225  
               
  Cash and Cash Equivalents, End of Period   $   1,484,099   $   2,371,266  
               
  Supplemental Disclosure of Cash Flow Information:          
    Cash paid during the year:          
    Interest paid   $   1,618   $   -  
    Income taxes paid   $   -   $   -  
    Non-Cash Financing Activity:          
    Warrant liability - reclassification to equity   $   692,110   $   -  
   

Investor Relations Contact: David Waldman/Natalya Rudman Crescendo Communications, LLC Tel. +1 855-379-9900 ltbr@crescendo-ir.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 48

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 35

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AI-Designed Antivirals: A Brave New World

Updated Category News Views 4

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...

Continue Reading
New Chapter Recovery Garners Key Accreditations

Updated Category News Views 4

Accreditations That Matter It's not every day a treatment facility pops its head up with credentials that weigh like a ton of bricks. New Chapter Recovery in New Jersey just snagged two heavy hitters: Joint Commission accreditation and LegitScript certification. These badges don’t just glimmer for show; they’re the market's assurance against empty promises—an...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 42

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 4

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 7

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 46

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Facing Class Action: Deadline Looms for Investors

Updated Category News Views 4

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

Continue Reading
TomoIQ Unveils Money Finder at Money20/20 Event

Updated Category News Views 5

Breaking Down Financial Barriers with AI In the hustle of Money20/20 USA in Las Vegas, TomoIQ dropped a financial bombshell with their latest tool, Money Finder. This isn't just another app in the sea of fintech solutions. Nope, this one promises to cut through the complexities that most folks face when trying to get their financial house in order. An AI Buddy for...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Investor Sentiment on Novo Nordisk Options Trading

Updated Category News Views 120

Investor Insights into Novo Nordisk Options Trading In the dynamic landscape of stock trading, the behavior of high-value investors often reveals critical insights into future market movements. Recently, attention has shifted toward Novo Nordisk (NYSE: NVO), where wealthy investors have exhibited a notably bearish outlook. This significant trend is something that small...

Continue Reading
Understanding Patient Concerns About Cancer Diagnoses

Updated Category News Views 104

Insights from Ibex Medical Analytics on Cancer Diagnoses A recent survey has shed light on the fears and uncertainties many patients encounter when faced with potential cancer diagnoses. Ibex Medical Analytics, known for its innovative use of artificial intelligence (AI) in cancer diagnostics, identified key findings that highlight the emotions and perceptions of...

Continue Reading
OpenAI Partners with Samsung and SK Hynix: AI Impacts Market

Updated Category News Views 198

OpenAI's Revolutionary Memory Deal In a significant move, OpenAI has established a preliminary agreement with major players in the tech industry, specifically South Korean giants Samsung Electronics Co Ltd and SK Hynix. This partnership is poised to reshape the landscape of artificial intelligence (AI) by addressing critical memory needs for AI systems. Significance of...

Continue Reading
Worksport's Terravis Energy Set to Transform Heat Pump Technology

Updated Category News Views 208

Innovative Heat Pump Technology by Worksport's Terravis Energy Worksport Ltd. (NASDAQ: WKSP) is making significant strides in the clean technology space with its subsidiary Terravis Energy. This innovative company is focused on the development of cutting-edge heat pump technologies that are gaining attention in the multi-billion-dollar market. Exciting Partnership with...

Continue Reading
Ascom's 2024 Challenges and Future Growth Plans Revealed

Updated Category News Views 285

Ascom’s 2024 Financial Overview Ascom recently reported its financial results for 2024, showcasing a mix of challenges and opportunities for growth despite a declining revenue stream. The company's net revenue reached CHF 286.7 million, reflecting a decrease compared to the CHF 297.3 million achieved in 2023. This decline equates to a 1.6% decrease when looking at...

Continue Reading